Nathaniel Harding
Managing Partner @ Cortado Ventures
Nathaniel Harding is a seed investor at Cortado Ventures focused on Health Care and Energy. Nathaniel Harding is the Managing Partner of Cortado Ventures. He previously worked at Harding & Shelton Exploration, LLC as a President. Nathaniel Harding attended the University of Oklahoma.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Nathaniel Harding invests in
Stages Nathaniel Harding invests in
Countries Nathaniel Harding invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 4 (44%)
- Energy 1 (11%)
- Delivery 1 (11%)
- Robotics 1 (11%)
- Software 1 (11%)
Stage
- Seed 3 (33%)
- Series A 2 (22%)
- Pre-Seed 1 (11%)
- Series B 1 (11%)
- Funding Round 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Tobe Energy is a hydrogen production technology company that manufactures electrolysis and power electronics systems. | $1.8M / Seed / Sep 04, 2025 | ||
| Lumata Health is a technology-driven healthcare startup focused on preventing blindness from chronic eye conditions, managing thousands of people at risk of vision loss across the United States. Founded in 2017 by an ophthalmologist and retina specialist in practice for over 30 years, Stephen R. Fransen, MD, and supported by more than 30 industryluminaries and influencers on its Advisory Board, Lumata Health aims to stop preventable blindness with a human-led, intelligent care coordination and management platform that’s almost always free to the patient. The company partners with physicians, payers and health systems to offer turnkey care management services provided by eye care experts who are supported by cutting edge technology and data science. Lumata Health’s programs improve clinical outcomes, patient satisfaction, and clinic staff efficiency by providing between-visit patient assistance and care coordination for patients with chronic eye diseases such as diabetic retinopathy, macular degeneration, glaucoma, and dry eye. | $23M / Series B / Mar 05, 2025 | ||
| Apricot is the solution for completing accurate, compliant OASIS and routine visit paperwork while employing generative AI technology to do the hard lifting so that home health nurses may focus on patient care. | Venture - Series Unknown / May 20, 2024 | ||
| CorriXR Therapeutics is a biotechnology company. The company is headquartered in Wilmington, Delaware, United States. | Seed / Jan 16, 2024 | ||
| Lumata Health is a technology-driven healthcare startup focused on preventing blindness from chronic eye conditions, managing thousands of people at risk of vision loss across the United States. Founded in 2017 by an ophthalmologist and retina specialist in practice for over 30 years, Stephen R. Fransen, MD, and supported by more than 30 industryluminaries and influencers on its Advisory Board, Lumata Health aims to stop preventable blindness with a human-led, intelligent care coordination and management platform that’s almost always free to the patient. The company partners with physicians, payers and health systems to offer turnkey care management services provided by eye care experts who are supported by cutting edge technology and data science. Lumata Health’s programs improve clinical outcomes, patient satisfaction, and clinic staff efficiency by providing between-visit patient assistance and care coordination for patients with chronic eye diseases such as diabetic retinopathy, macular degeneration, glaucoma, and dry eye. | $4M / Series A / Oct 27, 2022 | ||
| Pipedream Labs is a logistics solution company that offers hyper-logistics services. They include hyperlogistics, logistics, robotics, delivery, boring, drilling, deep tech, engineering, and clean energy. Their customers' inquiries are addressed through phone, email, and online applications. | $1.6M / Pre-Seed / Oct 25, 2021 | ||
| Digitize and automate data collection and business processes in a no-code environment | Seed / Oct 07, 2020 | ||
| Sway develops an FDA-cleared mobile software application that monitors signs of musculoskeletal, neurological, and vestibular dysfunction. It was founded in 2011 and is based in Aledo, Texas. | $4M / Series A / Jul 10, 2020 | ||
| See all 9 investments → | |||
Co-Investors
About Cortado Ventures
Cortado Ventures invest in capital-efficient businesses that leverage technology to scale in the fintech, biotech, aerospace, ag tech, and energy tech. It was founded in 2020 and headquartered in Oklahoma, United States. Intake form: https://cortado.ventures/contact-us/
Cortado Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
David Woods
Co-Founder and Partner
|
|||
Mike Moradi
Co-Founder & Venture Partner
|
|||
|
Nathaniel Harding
Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Nathaniel Harding invest in?
Nathaniel Harding invests primarily in Health Care, Energy and Delivery startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Nathaniel Harding?
Public channels for Nathaniel Harding include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Nathaniel Harding last invest?
The most recent investment recorded for Nathaniel Harding closed in Sep 2025. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
